Analysis and Perspectives

Jul 21, 2026

Several prominent companies in the Systemic Lupus Erythematosus (SLE) Treatment Market such as ImmuPharma, AstraZeneca, UCB, Roche, ImmuPharma

Jul 10, 2026

The Charcot-Marie-Tooth disease treatment landscape is standing at a genuine inflection point. For decades, care has been built almost entirely around bracing, physiotherapy, and pain management, necessary but incapable of altering the underlying course of the disease.

Jul 03, 2026

The launch of therapies in Developmental and Epileptic Encephalopathy Market like Epidiolex and Fintepla to transform treatment scenarios.

Jun 19, 2026

Several types of cardiac devices, such as pacemakers, stents, and defibrillators, are available for the treatment of Cardiovascular Diseases

Jun 19, 2026

Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...

Jun 18, 2026

Medical Robots Market is expected to observe immense growth due to the active participation of the MedTech and HealthTech companies in the

May 13, 2026

In today's highly dynamic and fast-changing market, Competitive Intelligence plays a crucial role in making strategically smart decisions to outsmart the competition

Mar 25, 2026

DelveInsight estimates that the total market size for hypophosphatasia in the 7MM was nearly $1 billion in 2023, and it is expected to grow at a CAGR of 7.2% by 2034. This growth is anticipated to be driven by the introduction of new therapies, such as AstraZeneca’s ALXN1850 (efzimfotase alfa), AM Pharma’s Ilofotase alfa, and others, and increased disease awareness.

Mar 25, 2026

Future of nephrotic syndrome treatment holds promise advancements in precision medicine as the market size in 7MM to grow from $401M in 2022.

Mar 18, 2026

Potential therapies are being investigated for retinal vein occlusion treatment. Even though it is too soon to comment on the promising candidate to enter the market, it is safe to assume that the future of the retinal vein occlusion treatment market is promising.